Association of Time in Range, As Assessed by Continuous Glucose Monitoring, with Painful Diabetic Polyneuropathy

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2020 Sep 5

PMID 32885597

Citations 25

Authors

Junpeng Yang

Xueli Yang

Dongni Zhao

Xiaobing Wang

Wei Wei

Huijuan Yuan

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: This study aimed to evaluate the association between time in range (TIR) obtained from continuous glucose monitoring and the prevalence and degree of painful diabetic neuropathy.

Materials And Methods: A total of 364 individuals with diabetic peripheral neuropathy were enrolled in this study. Sensor-based flash glucose monitoring systems were used to monitor the participants' glucose levels, and the glycemic variability metrics were calculated, including the TIR, glucose coefficient of variation, standard deviation and the mean amplitude of glycemic excursions. The participants were asked to record any form of pain during the 2 weeks of monitoring, and score the pain every day on a numerical rating scale. Based on the numerical rating scale, the patients were divided into the pain-free group, mild pain group and moderate/severe pain group.

Results: Overall, 51.92% (189/364) of the participants were diagnosed with painful diabetic neuropathy. Compared with the pain-free group, the level of TIR decreased significantly in the mild pain and moderate/severe pain groups (P < 0.05). The prevalence of mild pain and moderate/severe pain decreased with increasing TIR quartiles (all P < 0.05). Multiple linear regression analysis showed that TIR was significantly negatively correlated with the numerical rating scale score after adjustment for glycated hemoglobin, glycemic variability indicators and other risk factors (P < 0.05). Logistic regression analysis showed that a decreasing level of TIR was significantly associated with an increasing risk of any pain and moderate/severe pain (P < 0.05).

Conclusions: TIR is correlated with painful diabetic neuropathy and is underscored as a valuable clinical evaluation measure.

Citing Articles

Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study.

Ajjan R, Battelino T, Seufert J, Blin P, de Pouvourville G, Vicaut E BMJ Open. 2025; 15(1):e085961.

PMID: 39779259 PMC: 11749619. DOI: 10.1136/bmjopen-2024-085961.

Diabetic Peripheral Neuropathy and Glycemia Risk Index in Type 2 Diabetes: A Cross-Sectional Study.

Tang Y, Zhang P, Li L, Li J Diabetes Metab Syndr Obes. 2024; 17:4191-4198.

PMID: 39526203 PMC: 11550701. DOI: 10.2147/DMSO.S482824.

The application of artificial intelligence in diabetic retinopathy: progress and prospects.

Xu X, Zhang M, Huang S, Li X, Kui X, Liu J Front Cell Dev Biol. 2024; 12:1473176.

PMID: 39524224 PMC: 11543434. DOI: 10.3389/fcell.2024.1473176.

Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients.

Chang K, Pai Y, Lin C, Lee I, Chang M Sci Rep. 2024; 14(1):22276.

PMID: 39333368 PMC: 11436730. DOI: 10.1038/s41598-024-73472-y.

Treatment of Painful Diabetic Neuropathy with 10 kHz Spinal Cord Stimulation: Long-Term Improvements in Hemoglobin A1c, Weight, and Sleep Accompany Pain Relief for People with Type 2 Diabetes.

Klonoff D, Levy B, Jaasma M, Bharara M, Edgar D, Nasr C J Pain Res. 2024; 17:3063-3074.

PMID: 39308991 PMC: 11416775. DOI: 10.2147/JPR.S463383.

References

Carracher A, Marathe P, Close K . International Diabetes Federation 2017. J Diabetes. 2018; 10(5):353-356. DOI: 10.1111/1753-0407.12644. View

Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman K . Standardizing Clinically Meaningful Outcome Measures Beyond HbA for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the.... Diabetes Care. 2017; 40(12):1622-1630. PMC: 5864122. DOI: 10.2337/dc17-1624. View

Wang L, Lin P, Ma A, Zheng H, Wang K, Li W . C-Peptide Is Independently Associated with an Increased Risk of Coronary Artery Disease in T2DM Subjects: A Cross-Sectional Study. PLoS One. 2015; 10(6):e0127112. PMC: 4476669. DOI: 10.1371/journal.pone.0127112. View

AlGeffari M . Painful Diabetic Peripheral Neuropathy among Saudi Diabetic Patients is Common but Under-recognized: Multicenter Cross-sectional study at primary health care setting. J Family Community Med. 2018; 25(1):43-47. PMC: 5774042. DOI: 10.4103/jfcm.JFCM_145_16. View

Shillo P, Sloan G, Greig M, Hunt L, Selvarajah D, Elliott J . Painful and Painless Diabetic Neuropathies: What Is the Difference?. Curr Diab Rep. 2019; 19(6):32. PMC: 6505492. DOI: 10.1007/s11892-019-1150-5. View

Suzuki D, Yamada H, Yoshida M, Funazaki S, Amamoto M, Morimoto J . Sodium-glucose cotransporter 2 inhibitors improved time-in-range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single-center, pilot study. J Diabetes Investig. 2020; 11(5):1230-1237. PMC: 7477508. DOI: 10.1111/jdi.13240. View

Pai Y, Lin C, Lee I, Chang M . Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metab. 2018; 44(2):129-134. DOI: 10.1016/j.diabet.2018.01.015. View

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J, Rayman G . Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. Diabetes Ther. 2016; 8(1):55-73. PMC: 5306122. DOI: 10.1007/s13300-016-0223-6. View

Themistocleous A, Ramirez J, Shillo P, Lees J, Selvarajah D, Orengo C . The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain. 2016; 157(5):1132-1145. PMC: 4834814. DOI: 10.1097/j.pain.0000000000000491. View

10.

Danne T, Nimri R, Battelino T, Bergenstal R, Close K, DeVries J . International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017; 40(12):1631-1640. PMC: 6467165. DOI: 10.2337/dc17-1600. View

11.

Oyibo S, Prasad Y, JACKSON N, Jude E, Boulton A . The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002; 19(10):870-3. DOI: 10.1046/j.1464-5491.2002.00801.x. View

12.

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

13.

Javed S, Hayat T, Menon L, Alam U, Malik R . Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabet Med. 2019; 37(4):573-579. DOI: 10.1111/dme.14194. View

14.

Hebert H, Veluchamy A, Torrance N, Smith B . Risk factors for neuropathic pain in diabetes mellitus. Pain. 2016; 158(4):560-568. PMC: 5359789. DOI: 10.1097/j.pain.0000000000000785. View

15.

Arumugam T, Razali S, Vethakkan S, Rozalli F, Shahrizaila N . Relationship between ultrasonographic nerve morphology and severity of diabetic sensorimotor polyneuropathy. Eur J Neurol. 2015; 23(2):354-60. DOI: 10.1111/ene.12836. View

16.

Tamborlane W, Beck R, Bode B, Buckingham B, Peter Chase H, Clemons R . Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14):1464-76. DOI: 10.1056/NEJMoa0805017. View

17.

Jung H . Clinical Implications of Glucose Variability: Chronic Complications of Diabetes. Endocrinol Metab (Seoul). 2015; 30(2):167-74. PMC: 4508260. DOI: 10.3803/EnM.2015.30.2.167. View

18.

Pop-Busui R, Boulton A, Feldman E, Bril V, Freeman R, Malik R . Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2016; 40(1):136-154. PMC: 6977405. DOI: 10.2337/dc16-2042. View

19.

Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H . Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009; 35(3):206-13. DOI: 10.1016/j.diabet.2008.11.004. View

20.

Alkhatatbeh M, Abdul-Razzak K . Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2019; 7(1):e000690. PMC: 6577304. DOI: 10.1136/bmjdrc-2019-000690. View